5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is Segmented By Technology (In Vitro-fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Replacement (FER), and others), By End-Users (Hospital, and Fertility Clinics), and Geography
One of the major factors driving the growth of the ART market is the increasing number of infertility cases across the world. For instance, according to estimates of Centers for Disease Control and Prevention (CDC), in the United States, 12.1% of women aged in between 15-44 suffer from impaired fecundity, whereas, 6.7% of married women in the same age group are infertile. This, in turn, is expected to propel the demand for ART technologies. Hence, the rise in infertility cases across the world is expected to boost market growth over the forecast period. Other factors such as the rise in the number of single women and same-sex couples and increase in awareness for IVF and surrogacy is expected to drive the growth of the market over the forecast period.
The high cost and socio-ethical issues involved are expected to restrict the growth of the ART market over the forecast period. This technology can raise the number of complicated ethical issues for the individuals involved, such as health care professionals, and for the greater part of society. For instance, one of the crucial issues associated with ART is the safety of embryos whether they are inside of a mother's body or in a laboratory. In addition to this, ART is very costly. These factors are expected to restrain the growth of the market.
Assisted Reproductive Technology (ART) is used to treat infertility. In vitro fertilization (IVF) is the most common and effective type of ART. Whereas, multiple pregnancy condition is the most common complication associated with ART. The major factors propelling the growth of this market are the rise in the number of infertility cases owing to obesity, the rise in stress and pollution, and increasing number of smokers across the world.
|In Vitro-fertilization (IVF)|
|Artificial Insemination (AI-IUI)|
|Frozen Embryo Replacement (FER)|
|By End Users|
Report scope can be customized per your requirements. Click here.
The IVF is expected to grow during the forecast period due to the high procedural success rate coupled with continuous advancement. The increasing number of IVF treatments has encouraged more insurance providers to cover these procedures. This has ultimately led to competitive pricing and has moderated the treatment costs. In 2016, the Ontario government announced a USD 50 million fertility program to cover IVF treatment for 5,000 people.
The market is driven by increasing incidence of infertility owing to lifestyle changes, government initiatives to provide better reimbursement policies. This is projected to positively influence the market growth in forecast years.
To understand key trends, Download Sample Report
Europe dominated ART market and is expected to retain its dominance over the forecast period owing to rising awareness among people for infertility treatment, technological advancements, government initiatives to promote appropriate ART facilities, and increasing number of infertility cases in the region. The Centers for Disease Control and Prevention (CDC) have developed the National Public Health Action Plan with an aim to prevent, detect, and manage the infertility cases around the world. Most of the EU Member States have considered infertility a medical condition and their national policies fund ranges from the entire treatment to some portion of infertility treatment. All the afore mentioned factors are expected to propel the growth of this market over the forecast period.
To understand geography trends, Download Sample Report.
The major player in Assisted Reproductive Technology (ART) market includes - Bloom IVF Centre, CooperSurgical Inc., Ferring B.V., Hamilton Thorne Inc., FUJIFILM Irvine Scientific, Inc., Laboratoire CCD, Microm Ltd, Nidacon International AB, OvaScience Inc., and Vitrolife.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Infertility Cases
4.2.2 Rise in Number of Single Women and Same-sex Couples
4.2.3 Increase in Awareness for IVF and Surrogacy
4.3 Market Restraints
4.3.1 High Cost and Socio-ethical Issues
4.3.2 Changing Government Regulations
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Technology
5.1.1 In Vitro-fertilization (IVF)
5.1.2 Artificial Insemination (AI-IUI)
5.1.3 Frozen Embryo Replacement (FER)
5.2 By End Users
5.2.2 Fertility Clinics
5.3.1 North America
126.96.36.199 United States
188.8.131.52 Rest of Europe
5.3.3 Asia Pacific
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East and Africa
5.3.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bloom IVF Centre
6.1.2 CooperSurgical Inc.
6.1.3 Ferring B.V.
6.1.4 Hamilton Thorne Inc.
6.1.5 FUJIFILM Irvine Scientific, Inc.
6.1.6 Laboratoire CCD
6.1.7 Microm Ltd
6.1.8 Nidacon International AB
6.1.9 OvaScience Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS